Profile for Australia Patent: 2019331490
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Australia Patent: 2019331490
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Aug 30, 2039 | Intra-cellular | CAPLYTA | lumateperone tosylate |
| ⤷ Start Trial | Aug 30, 2039 | Intra-cellular | CAPLYTA | lumateperone tosylate |
| ⤷ Start Trial | Aug 30, 2039 | Intra-cellular | CAPLYTA | lumateperone tosylate |
| ⤷ Start Trial | Aug 30, 2039 | Intra-cellular | CAPLYTA | lumateperone tosylate |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
